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The effects of glucose on insulin biosynthesis were studied by measuring the incorporation ofradiolabelled 
amino acids into proinsulin/insulin in isolated rat islets. The islets were pulse labelled for 15 rain with 
[3H]ieucine (present in rat insulin I and II) or [35S]methionine (unique to rat insulin II) and then incubated 
for a 165 min post-label (chase) period during which the majority of labelled proinsulin was converted to 
insulin but under conditions whereby > 95% of radiolabelled proinsulin or insulin was retained in the islets. 
The newly synthesized, labelled, insulin was analyzed by high performance liquid chromatography. Rat I 
and II insulin biosynthesis was stimulated by 16.7 mM glucose to the same extent. 
Proinsulin synthesis; Insulin; Secretagogue stimulation; HPLC; (Islets of Langerhans, Rat) 
1. INTRODUCTION 
Insulin is produced in the B-cells of pancreatic 
islets from its precursor preproinsulin i  a series of 
coordinated biochemical and subcellular events 
[1]. Its biosynthesis can be rapidly and specifically 
stimulated by glucose and certain other 
secretagogues [2-4]. 
Unlike the majority of mammals, not one but 
two different insulins are present in the pancreas of 
rats [5,6] and mice [7,8]. In the rat, these two in- 
sulins are encoded for by two nonallelic genes 
[9,10] with the corresponding mRNAs showing 
about 93070 homology [11,12]. The primary 
translation products, rat preproinsulins I and II, 
differ by 3 amino acid substitutions in the signal 
peptide sequence, 2 in the C-peptide region and 2 
in the B-chain [9,121. Mouse insulins I and II are 
identical in sequence to those of the rat [7,8]. 
The biosynthesis of rat insulins I and II has been 
studied previously [6,13,14]. However, the issue of 
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whether glucose regulates the synthesis of both rat 
insulins I and II, although addressed, has remained 
unresolved due to inadequate resolution of rat in- 
sulin I from proinsulins and the non-quantitative 
transfer to nitrocellulose of rat insulin II with the 
immunoelectrophoretic system used [15-17]. To 
avoid such analytical problems, we have used high- 
performance liquid chromatography (HPLC) to 
monitor glucose stimulation of rat insulin I and II 
biosynthesis in isolated islets. 
2. EXPERIMENTAL 
Pancreatic islets were isolated from adult male 
CD rats by collagenase digestion [18]. Isolated 
islets were then maintained in tissue culture (RPMI 
1640 medium containing 8.3 mM glucose and 10070 
(v/v) newborn calf serum) for at least 18 h to 
recover from the isolation procedure. 
In order to monitor rat insulin biosynthesis, 
groups of 100 islets were pulse-labelled in 250/zl 
modified Krebs-Ringer bicarbonate buffer con- 
taining 10 mM Hepes and 0.1070 (w/v) bovine 
serum albumin, pH 7.4 (KRB-Hepes), in the 
Published by Elsevier Science Publishers B.V. (Biomedical Division) 
00145793/87/$3.50 © 1987 Federation ofEuropean Biochemical Societies 179 
Volume 215, number 1 FEBS 
presence of 0.25 mCi L-[4,5)H]leucine or L- 
[3SS]methionine, at a basal (2.8 mM) or 
stimulatory (16.7 mM) glucose concentration for 
15 min, at 37°C. The islets were then washed in 
ice-cold, unlabelled KRB-Hepes containing 
2.8 mM glucose and incubated for a 165 min post- 
label chase period at 37°C in 3 ml RPMI 1640 con- 
taining 2.8 mM glucose and 10°70 (v/v) newborn 
calf serum. The islets were then removed, washed 
in cold phosphate-buffered saline containing 0.1 °70 
(w/v) bovine serum albumin, pH 7.4 (PBS-BSA), 
suspended in 100/d PBS-BSA in 1.5 ml microfuge 
tubes, and stored at -20°C pending analysis. 
Islets suspended in 100/d PBS-BSA were 
sonicated (25 W, 10 s), and the sonicated debris 
pelleted by 1 rain centrifugation (10000 × g) in a 
microfuge. Aliquots (10/d) of this supernatant 
were then used to analyze radiolabelled amino acid 
incorporated into rat insulin I and II. Quantitative 
analysis of rat insulin I and II using HPLC was 
performed as described in [19]. In brief, the 
reversed-phase HPLC system is a C-18 column 
eluted isocratically with 35% acetonitri le:H20 
(9:1) and 650/0 50 mM phosphoric acid, 20 mM 
triethylamine, 50 mM sodium perchlorate adjusted 
to pH 3.0 with NaOH, at a flow rate of 1 ml/min. 
Rat insulins I and II both contain 6 leucine 
residues. Rat I insulin contains no methionine, but 
there is a substitution of a lysine for a methionine 
at residue 29 of the rat insulin II B-chain [2,15]. 
The use of [35S]methionine instead of [3H]leucine 
in the pulse-labelling period therefore allows for 
monitoring of only rat insulin II biosynthesis. 
3. RESULTS 
An HPLC elution profile of a representative ali- 
quot of sonicated rat islets taken after a 15 min 
pulse label with [3H]leucine and a 165 min chase, 
is shown in fig.1. Radioactivity eluting from the 
HPLC system was found associated with both rat 
insulin I (eluting at 30-35 min) and rat insulin II 
(eluting at 38-43 min). These two peaks of 
radioactivity associated with insulin coincided with 
two peaks of UV absorbance at 213 nm. When 
[35S]methionine was used in place of [~H]leucine 
for pulse labelling, radioactivity was only detected 
in the insulin II peak in accordance with the known 
primary sequence of the two rat insulins [2,15]. 
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Fig.1. HPLC elution profile for the separation of rat 
insulins I and II following pulse labelling of islets for 
15 min with [~H]leucine ( ) or [35S]methionine ( . . . )  
and a 165 min chase. The known elution times for the 
two insulins are shown by the numbered arrows. The 
inset shows UV absorbance (A21~ x 10 -3) for the HPLC 
analysis of the sample which had been labelled with 
[3H]leucine. 
There was always more insulin I than insulin II 
whether measured in terms of [3H]leucine incor- 
poration (reflecting newly synthesized insulins) or 
UV absorbance at 213 nm (reflecting total islet in- 
sulin content). 
Although we [19] and others [20] have described 
methods for the separation of rat insulins I and II 
by HPLC,  such is not the case for the two rat pro- 
insulins. Here, it was therefore necessary to ensure 
that essentially all labelled proinsulin had been 
converted to insulin before analysis. This was 
achieved by incubating the pulse-labelled islets for 
165 min at 2.8 mM glucose. It has been shown 
previously that > 95°70 of newly synthesized proin- 
sulin is converted to insulin within 180min 
[2,19,21]. Furthermore, by selecting a low glucose 
concentration (2.8 mM) for the chase incubation, 
it was possible to ensure that the majority of the 
labelled insulin was retained in the islets rather 
than being released [21]. Under such conditions, 
the measurement of radioactivity in rat insulins I 
and II can therefore be used as an index of their 
respective rates of synthesis. These data are shown 
in table 1. The radioactivity in insulin I or II for 
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Table 1 
Glucose stimulation of the incorporation of radiolabelled amino acids into 
rat insulins I and II 
Rat Radiolabelled Radioactivity in Fold- 
insulin amino acid insulin (cpm/ng) stimulation 
Glucose (mM) 2.8 16.7 16.7 vs 2.8 
I [3H]leucin e 40.0 + 3.1 81.6 + 8.2 2.43 + 0.11 
II 10.4 _+ 0.6 26.7 _ 3.4 2.61 + 0.38 
II [35S]methionine 6.3 + 1.0 6.7 _ 2.3 2.45 + 0.16 
Islets were pulse-labelled with the given amino acid for 15 min at either 2.8 
or 16.7 mM glucose. The islets were then incubated for a 165 min chase 
period without radioactivity a  2.8 mM glucose. Radioactivity in insulins I 
or II was assessed by HPLC and the data (means _+ SE, n = 3-5 separate 
experiments) expressed as cpm/ng total islet insulin immunoreactivity 
(measured by radioimmunoassay prior to HPLC). Note that here is no 
methionine in rat insulin I 
each experiment has been normalized to the total 
islet insulin content (i.e. the combined im- 
munoreactivity of insulins I and II) as measured by 
radioimmunoassay [22] before HPLC analysis. In 
agreement with the HPLC profile shown in fig.l, 
there was always more radioactivity in insulin I 
than II. Raising glucose from 2.8 to 16.7 mM was 
found to stimulate the labelling of both insulin I 
and II to the same extent, and the data obtained 
for insulin II using [3H]leucine were similar to 
those using [35S]methionine. The ratio of radioac- 
tivity in insulin I relative to that in insulin II, 
however, was the same following a pulse label with 
[3H]leucine at either 2.8 or 16.7 mM glucose. 
4. DISCUSSION 
The specific and rapid stimulation of proin- 
sulin/insulin biosynthesis by elevated extracellular 
glucose concentrations has been known for over 
20 years [2-4,23]. The short-term (<2 h) regula- 
tion of insulin biosynthesis appears to be indepen- 
dent of net preproinsulin mRNA synthesis and 
thus arises at a translational level [24-27]. There 
appears to be a shift of cytoplasmic free preproin- 
sulin mRNA to membrane-bound polysomes 
leading to increased synthesis of proinsulin upon 
glucose stimulation [25,26]. Exposure to glucose 
for >2 h, however, has been shown to result in in- 
creased preproinsulin mRNA synthesis. In the pre- 
sent study, isolated rat islets were only subjected to 
short-term glucose stimulation (15 rain) and 
glucose stimulation of synthesis was therefore 
limited to the translational effects. 
The glucose regulation of the biosynthesis of rat 
insulins I and II in isolated islets has been studied 
previously [15], and it was suggested that synthesis 
of insulin I was stimulated to a greater extent han 
that of rat insulin II. It has since become apparent 
that these conclusions were incorrect, since there 
were inherent problems in interpreting the data due 
to inadequate separation and/or  non-quantitative 
recovery of rat insulins and proinsulins by the elec- 
trophoretic system used [17]. In this study, we have 
depended upon a separation system previously 
shown [19] to (i) be quantitative, and (ii) resolve 
rat insulins I and II. Our data indicate un- 
equivocally that 16.7 mM glucose stimulates rat in- 
sulin I and II biosynthesis to an equal extent (about 
2.5-fold). 
Rat I and II preproinsulin mRNA levels have 
been measured in rat islets [31] and insulinoma 
ceils [30,32] and shown to be present in approx- 
imately equal amounts. It has, furthermore, been 
shown that both rat preproinsulin mRNAs appear 
to be regulated coordinately in vivo following 
fasting and refeeding of rats with sucrose [31]. In 
the present study there was more rat I than II in- 
sulin in islets, whether measured by radioactivity 
after biolabelling with [3H]leucine or by UV ab- 
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sorption (and radioimmunoassay; not shown) 
following HPLC analysis. High levels of rat I 
relative to II insulin have been found by others in 
both native [6,13,14] and transformed [30] B-cells. 
The discrepancy between the data for the mRNA 
levels compared with those of the native insulins 
remains to be explained but must presumably 
reflect differential rates of protein turnover and/or 
different ranslation efficiency for the two mRNA 
species. Regardless of the final explanation, our 
data confirm that insulin biosynthesis can be 
stimulated by glucose during a 15 min pulse- 
labelling period. This effect is presumed to be due 
to stimulation of translation, and occurs to an 
equal extent for both rat insulins. 
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